The Suppressive Effect of Carthamin Yellow on the Proliferation and Migration of Human Breast Cancer Cells and Its Related Molecular Mechanisms

Kong Xiang Dong; Yuan Shao Feng; Pan Liang Ming; Zeng Lin Wen; Wu Ming; Shen Jian Liang

Article Contents

Article Navigation > Journal of Kunming Medical University > 2018 > 39(01): 20-25

Kong Xiang Dong , Yuan Shao Feng , Pan Liang Ming , Zeng Lin Wen , Wu Ming , Shen Jian Liang . The Suppressive Effect of Carthamin Yellow on the Proliferation and Migration of Human Breast Cancer Cells and Its Related Molecular Mechanisms[J]. Journal of Kunming Medical University, 2018, 39(01): 20-25.

Citation:

Kong Xiang Dong , Yuan Shao Feng , Pan Liang Ming , Zeng Lin Wen , Wu Ming , Shen Jian Liang . The Suppressive Effect of Carthamin Yellow on the Proliferation and Migration of Human Breast Cancer Cells and Its Related Molecular Mechanisms[J]. Journal of Kunming Medical University, 2018, 39(01): 20-25.

Citation:

Kong Xiang Dong , Yuan Shao Feng , Pan Liang Ming , Zeng Lin Wen , Wu Ming , Shen Jian Liang . The Suppressive Effect of Carthamin Yellow on the Proliferation and Migration of Human Breast Cancer Cells and Its Related Molecular Mechanisms[J]. Journal of Kunming Medical University, 2018, 39(01): 20-25.

PDF( 935 KB)

The Suppressive Effect of Carthamin Yellow on the Proliferation and Migration of Human Breast Cancer Cells and Its Related Molecular Mechanisms

Funds:

基金：上海市金山区卫生系统“优秀青年人才”培养计划基金资助项目 (JSYQ201620); 上海市金山区科学技术创新基金资助项目 (2015-3-24); 上海市金山区医疗卫生学科建设基金资助项目 (JSZK2015B06);

Received Date: 2017-05-21

Abstract

Abstract

Objective To study the effect of Carthamin Yellow (CY) on cell proliferation, apoptosis, migration and invasion ability of breast cancer and its related molecular mechanisms. Methods CCK-8 assay was used to detect cell viability of MDA-MB-231 human breast cancer cells by different concentrations of CY at different time;flow cytometry was used to test the apoptosis rate of MDA-MB-231 cells treated by different concentrations of CY and transwell assay was used to investigate the effect of various concentrations of CY on MDA-MB-231 cell migration and invasion.After the intervention of different concentrations of CY on MDA-MB-231 cells, apoptosis-related protein Cleaved-Caspase-3, survival protein p-Akt and metastasis-related protein MMP2 were detected by western blot. Results (1) CY could inhibit the proliferation of MDA-MB-231 cells in a dose-andtime-dependent manner. (2) CY significantly promoted the apoptosis of breast cancer cells (P<0.01) . (3) CY could decrease the expression of p-Akt and increase the expression of Cleaved-Caspase-3. (4) CY impaired migration and invasion of MDA-MB-231 cells (P<0.01) , and can inhibit the expression of MMP2. Conclusion CY could promote the apoptosis of breast cancer cells through activation of apoptosis signaling, and can inhibit breast cancer cell metastasis by suppressing MMP2. And CY may be a potential therapeutic drug for human breast cancer.
- Carthamin Yellow,
- Breast cancer cell,
- Proliferation,
- Apoptosis,
- Migration and invasion

FullText(HTML)

References(27)

References

[1]	[1]MASUDA N, LEE S J, OHTANI S, et al.Adjuvant capecitabine for breast cancer after preoperative chemotherapy[J].N Engl J Med, 2017, 376 (22) :2147-2159.
[2]	[2]DENGFENG L I, JIASHU H U, HONGMING SONG, et al.mi R-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells[J].Am J Transl Res, 2017, 9 (5) :2276-2285.
[3]	[3]ZHIHAO ZENG, XIAOWU CHEN, DAJIAN ZHU, et al.Low expression of circulating micro RNA-34c is associated with poor prognosis in triple-negative breast cancer[J].Yonsei Med J, 2017, 58 (4) :697-702.
[4]	[4]XUE WANG, NAN ZHENG, JING DONG, et al.Estrogen receptor-alpha36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells[J].J Steroid Biochem Mol Biol, 2017, 171 (7) :318-327.
[5]	[5]DESHENG LIANG, WENJIE ZHANG, AITING WANG, et al.Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles[J].Biomaterials, 2017, 137 (5) :23-36.
[6]	[6]YUN CAI, BOXIN ZHAO, QIANYING LIANG, et al.The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIalpha and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231cells[J].Eur J Pharmacol, 2017, 809 (8) :87-97.
[7]	[7]HAMER J, WARNER W.Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health[J].Cmaj, 2017, 189 (7) :E268-e274.
[8]	[8]LIBING ZHU, LINGRU L I, YINGSHUAI LI, et al.Chinese herbal medicine as an adjunctive therapy for breast cancer:A systematic review and meta-analysis[J].Evid Based Complement Alternat Med, 2016, (18, supplement) :9469276.
[9]	[9]CHINGCHIUNG WANG, CHEUKSING CHOY, YUNGHUNG LIU, et al.Rotective effect of dried safflower petal aqueous extract and its main constituent, carthamus yellow, against lipopolysaccharide-induced inflammation in RAW264.7 macrophages[J].J Sci Food Agric, 2011, 91 (2) :218-25.
[10]	[10]SIYUAN FAN, NAN LIN, GUANGLIANG SHAN, et al.Safflower yellow for acute ischemic stroke:A systematic review of randomized controlled trials[J].Complement Ther Med, 2014, 22 (2) :354-61.
[11]	[11]TAKAHASHI Y, MIYASAKA N, TASAKA S, et al.Constitution of two coloring matters in the flower petals of Carthamus Tinctorius L[J].Tetrahedron Letters, 1982, 23 (49) :5163-5166.
[12]	[12]MINXIN ZHOU, JIANHUA F U, QIONG ZHANG, et al.Effect of hydroxy safflower yellow A on myocardial apoptosis after acute myocardial infarction in rats[J].Genet Mol Res, 2015, 14 (2) :3133-3341.
[13]	[13]XIUGUO HAN, LIN DU, HAN QIAO, et al.CXCR1knockdown improves the sensitivity of osteosarcoma to cisplatin[J].Cancer Lett, 2015, 369 (2) :405-415.
[14]	[14]JINGJING SONG, YINGWU WANG, MEIYU TENG, et al.Cordyceps militaris induces tumor cell death via the caspasedependent mitochondrial pathway in Hep G2 and MCF7 cells[J].Mol Med Rep, 2016, 13 (6) :5132-5140.
[15]	[15]LEE W H, CHOONG L Y, JIN T H, et al.TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein[J].Oncogenesis, 2017, 6 (5) :e338.
[16]	[16]JINGYI L I, QIAN ZENG, YIXIN ZHANG, et al.Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14[J].Eur J Cell Biol, 2016, 95 (10) :368-377.
[17]	[17]XICHUN HU, WEI HUANG, MINHAO FAN, Emerging therapies for breast cancer[J].J Hematol Oncol, 2017.10 (1) :98.
[18]	[18]YI ZHANG, XU SUN, NAN NAN, et al.Elemene inhibits the migration and invasion of 4T1 murine breast cancer cells via heparanase[J].Mol Med Rep, 2017, 16 (1) :794-800.
[19]	[19]JIAN CHEN, JIEHUI TENG, LI M A, et al.Flavonoids isolated from the flowers of limonium bicolor and their in vitro antitumor evaluation[J].Pharmacogn Mag, 2017, 13 (50) :222-225.
[20]段培锋, 贾秀红, 王建勇.红花注射液对白血病HEL细胞增殖和凋亡的影响及相关机制探讨[J].中国当代儿科杂志, 2015, 17 (9) :989-993.
[21]	[21]JIANYING L I, JUN Y U, XUSHENG D U, et al.Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway[J].Oncol Rep, 2016, 36 (1) :147-154.
[22]	[22]XIUGUO HAN, YAN L I, HUIMIN M O, et al.TIMP3regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances[J].Tumour Biol, 2016, 37 (7) :8857-8867.
[23]	[23]HONGYU SHEN, LIANGPENG LI, SUJIN YANG, et al.Micro RNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3beta signaling pathway[J].Gene, 2016, 593 (1) :84-90.
[24]	[24]JIAYUN LIU, XIAOYU W U, GUANNAN W U, et al.FOXQ1 promotes cancer metastasis by PI3K/AKT signaling regulation in colorectal carcinoma[J].Am J Transl Res, 2017, 9 (5) :2207-2218.
[25]	[25]CHA H J, CHOI J H, PARK I C et al.Selective FGFR inhibitor BGJ398 inhibits phosphorylation of AKT and STAT3 and induces cytotoxicity in sphere-cultured ovarian cancer cells[J].Int J Oncol, 2017, 50 (4) :1 279-1 288.
[26]	[26]MENDES O, KIM H T, LUNGU G, et al.MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2[J].Clin Exp Metastasis, 2007, 24 (5) :341-351.
[27]	[27]BO LIU, JIAN CUI, JING SUN, et al.Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells[J].Mol Med Rep, 2016, 14 (2) :1 099-11 06.

Relative Articles(20)

Relative Articles

[1]	Ling WANG, Xiangchuan QIN, Jinqiu LI, Hasim AXIANGU. CD147 Mediates Cervical Cancer Cell Pyroptosis and Proliferation through AIM2 Inflammasome. Journal of Kunming Medical University, 2024, 45(1): 15-21. doi: 10.12259/j.issn.2095-610X.S20240103
[2]	Xiangchuan QIN, Jinqiu LI, Xiaojing HUANG, Kuerban HUTUBIDING·, Hasim AXIANGU·. Effect of HPV E6 on Proliferation，Invasion and Migration of Cervical Cancer Cells Through Rap1 Signaling Pathway. Journal of Kunming Medical University, 2024, 45(9): 9-16. doi: 10.12259/j.issn.2095-610X.S20240902
[3]	Yanping LI, Xiaolin¹ DONG, Qingyun LI, Hongmei LI, Huan WEI, Yi ZENG. miR-21-5p Alleviates OGD/R-induced Inflammation and Apoptosis of HT22 Cells and Promotes Proliferation by Inhibiting STAT3. Journal of Kunming Medical University, 2024, 45(12): 1-7.
[4]	Bangqing LIU, Jianfeng LI, Xiaohui LIU, Jinnan ZHANG, Jinping LIANG. MiR-196b Promotes Proliferation and Migration of Lung Adenocarcinoma by Targeting ERG. Journal of Kunming Medical University, 2023, 44(10): 83-91. doi: 10.12259/j.issn.2095-610X.S20231023
[5]	Tao HU, Yi WU, Wenda GENG, Yijian ZHANG, Xuan HE, Shanshan LI, Yanbin XIYANG, Liling DENG. Voluntary Exercise Training Attenuated the Proliferation and Growth of Human Breast Cancer with BRCA1 Mutation by Regulating Caspase-3 Activity. Journal of Kunming Medical University, 2023, 44(4): 31-39. doi: 10.12259/j.issn.2095-610X.S20230419
[6]	Yelin ZHANG, Liya MA, Xuhui PENG, Hefeng YANG, Rui SHE. Hsa-let-7a-5p Regulates Proliferation and Apoptosis of Periodontal Ligament Stem Cells. Journal of Kunming Medical University, 2023, 44(10): 47-54. doi: 10.12259/j.issn.2095-610X.S20231028
[7]	Liang ZHANG, Baoquan WANG, Xifeng LEI, Xu WANG, Yang KE, Wei ZHANG. Effect of miR-29c-3p/IGF1 Molecular Axis on Activation，Proliferation and Apoptosis of Hepatic Stellate Cells. Journal of Kunming Medical University, 2023, 44(9): 7-14. doi: 10.12259/j.issn.2095-610X.S20230926
[8]	Baoquan WANG, Wei ZHANG, Yuan TIAN, Xifeng LEI, Xu WANG. miR-142-5p Regulates the Proliferation and Metastasis of Gallbladder Carcinoma Cells through CCND1. Journal of Kunming Medical University, 2022, 43(2): 47-53. doi: 10.12259/j.issn.2095-610X.S20220223
[9]	Wei ZHANG, Baoquan WANG, Xifeng LEI, Xu WANG, Liang ZHANG. miR-125b-5p Regulates HK2 to Inhibit Proliferation and Glycolysis of Gallbladder Cancer Cells. Journal of Kunming Medical University, 2022, 43(12): 23-29. doi: 10.12259/j.issn.2095-610X.S20221206
[10]	Zhoujun LIAO, Shaohua YANG, Lixin LIU, Sheng HU, Yihui CHEN, Qiang KANG, Xiaowen ZHANG. Effect of AK4 on Proliferation and Migration of Intrahepatic Bile Duct Carcinoma Cell HUCCT1. Journal of Kunming Medical University, 2022, 43(6): 1-6. doi: 10.12259/j.issn.2095-610X.S20220611
[11]	Bin ZHAO, Yuanpeng DUAN, Guoying ZHANG, Chengwei BI, Libo YANG, Zhiyu SHI, Yong YANG, Jianpeng ZHANG, Ting GAO. CircRNA EZH2 Promotes Proliferation and Migration of Prostate Cancer Cells by Regulating miR-30c-5p. Journal of Kunming Medical University, 2022, 43(7): 25-32. doi: 10.12259/j.issn.2095-610X.S20220731
[12]	Lan YANG, Xiao JIA, Yi-tong JIANG, Qi CUI, Guang-ci LIU, Ying-hong HE. The Effect of Silencing of UBE2C Gene on the Proliferation and Migration of Human Gastric Cancer AGS Cells. Journal of Kunming Medical University, 2021, 42(5): 18-23. doi: 10.12259/j.issn.2095-610X.S20210504
[13]	Jian-wei SUN, Qian XIANG, Zi-chao LIU, Shan-shan XU, Ding DING. Effect of PTEN Gene Expression on Apoptosis of Thyroid Cancer Cells BCPAP and FTC133 and Expression of ERK and AKT. Journal of Kunming Medical University, 2021, 42(8): 23-30. doi: 10.12259/j.issn.2095-610X.S20210805
[14]	Ge Jia Yun . Effects of FHIT Overexpression Mediated by Slow Virus on the growth of Hepatoma Lines in Vitro. Journal of Kunming Medical University,
[15]	Liu Li Xin . . Journal of Kunming Medical University,
[16]	Bai Yu . . Journal of Kunming Medical University,
[17]	Wang Hai Feng . . Journal of Kunming Medical University,
[18]	Liu Jia Xin . . Journal of Kunming Medical University,
[19]	Xia Ying Jie . . Journal of Kunming Medical University,
[20]	Li Zhen . . Journal of Kunming Medical University,